Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05685121
Other study ID # 1926452
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 22, 2021
Est. completion date September 2024

Study information

Verified date January 2023
Source University of South Carolina
Contact R. Davis Moore, PhD
Phone 803-777-3278
Email moorerd3@mailbox.sc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to test a wearable nerve stimulator in adolescents with persistent post-concussive symptoms. The main questions it aims to answer is whether the device will reduce clinical symptom burden, reduce cognitive deficits, and aid in the recovery of clinical symptoms. Participants will wear the device daily for six weeks and complete a series of assessments.


Description:

The primary aim of this study is to evaluate the effectiveness of the Apollo Neuro Device on remediating clinical symptoms, cognitive deficits and physical symptoms of those patients struggling with persisting post-concussive symptoms. The Apollo Neuro Device offers a convenient novel, non-invasive, non-habit-forming solution to improve performance and recovery under stress by delivering gentle wave-like vibrations to the body that improve autonomic nervous system balance in real time. The investigators will carry out a prospective study including any individual over the age of ten years presenting with persisting post-concussive symptoms. An Apollo Neuro Device will be offered as part of a treatment plan to patients with chronic neurological symptoms and will be used as an adjunct along with typical treatment. Patients will follow-up for a comprehensive evaluation, per discretion of specialty physicians and weekly symptom surveys will also be emailed to patients to track status. The results of this study will further the understanding of autonomic dysfunction symptomology and recovery and evaluate the effect of nerve stimulation as a means of mediating autonomic nervous system dysfunction in these patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 10 Years and older
Eligibility Inclusion Criteria: - concussion diagnosis - able to follow simple instruction - able to sit upright in a chair for at least 30 minutes without rest Exclusion Criteria: - previous diagnosis of moderate or severe traumatic brain injury - neuropsychiatric conditions of schizophrenia or bipolar disorder - neurophysiological conditions of epilepsy, cerebral palsy, or severe sensory disorders

Study Design


Intervention

Device:
Apollo Neuro
The device is a wearable nerve stimulator.

Locations

Country Name City State
United States Prisma Health Pediatric Concussion Clinic Columbia South Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of South Carolina Prisma Health-Midlands

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weekly changes in concussion symptoms Index of concussion symptoms using the Sport Concussion Assessment Tool 5 (SCAT-5). The SCAT-5 assesses the presence and severity of 22 common concussion symptoms, each rated on a scale from 0 (not present) to 6 (severe). pre-intervention and weekly during the intervention
Primary Changes in executive function Observed functioning will be reported by parents/guardians with the Behavior Rating Inventory of Executive Function (BRIEF). The BRIEF includes t-scores for comparison to sex- and age-normed data, with higher values indicating worse outcomes. pre-intervention and after three and six weeks of device use
Primary Change in concussion symptoms from pre-injury levels Current severity of concussion symptoms in comparison to severity prior to injury will be assessed with the Rivermead Post-Concussion Symptoms Questionnaire (RPQ). The RPQ includes 16 concussion symptoms that are rated in comparison to pre-injury levels from 0 to 4, with higher scores indicating more severe symptoms. pre-intervention and after three and six weeks of device use
Primary Changes in anxiety symptoms Intensity of anxiety symptoms assessed with the Beck Youth Inventory - Anxiety scale. Raw scores range from 0 to 60, with higher scores indicating more severe symptoms. T-scores are also included for comparison to normative data. pre-intervention and after three and six weeks of device use
Primary Changes in depression symptoms Index of depression symptoms using the Beck Youth Inventory - Depression scale. Raw scores range from 0 to 60, with higher scores indicating more severe symptoms. T-scores are also included for comparison to normative data. pre-intervention and after three and six weeks of device use
Primary Changes in psycho-affective health Index of psycho-affective health using the Profile of Mood States (POMS). Higher scores on the POMS indicate more intensely experienced mood states. pre-intervention and after three and six weeks of device use
Primary Changes in sleep disturbance Index of sleep disturbance using the Neurological Quality of Life (Neuro-QoL) sleep subscale. Raw scores range from 0 to 32, with higher scores indicating worse sleep disturbance. T-scores are also included for comparison to normative data. pre-intervention and after three and six weeks of device use
Primary Changes in pain severity Index of pain using the Neurological Quality of Life (Neuro-QoL) pain sub-scale. Raw scores range from 0 to 40, with higher scores indicating worse pain. T-scores are also included for comparison to normative data. pre-intervention and after three and six weeks of device use
Primary Changes in fatigue Index of pain using the Neurological Quality of Life (Neuro-QoL) fatigue sub-scale. Raw scores range from 0 to 32, with higher scores indicating worse fatigue. T-scores are also included for comparison to normative data. pre-intervention and after three and six weeks of device use
Primary Changes in headache burden Index of headache-related burden using the Headache Impact Test-6 (HIT-6). Scores range from 36-78 with higher scores indicating worse outcomes. pre-intervention and after three and six weeks of device use
Primary Changes in cognitive function Performance on the CogState, a validated brain injury cognitive battery. pre-intervention and after three and six weeks of device use
Primary Changes in vestibular/ocular motor screening Visuomotor processing issues associated with concussion, assessed via the Vestibular/Ocular Motor Screening assessment (VOMS). pre-intervention and after three and six weeks of device use
Primary Changes in balance Neuromuscular control assessed via the Modified Balance Error Scoring Screen (mBESS). pre-intervention and after three and six weeks of device use
Primary Changes in heart rate variability Cardio-autonomic function recorded at rest and while under increased physiological demand during a hand grip task. pre-intervention and after three and six weeks of device use
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04109677 - AIM CONTROL and SWECON - Handball The SWEdish CONcussion Study in Elite Handball
Recruiting NCT04932278 - The Role of Osteopathic Manipulative Medicine in Recovery From Concussions N/A
Withdrawn NCT05062148 - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery N/A
Recruiting NCT05682677 - Combined Neuromodulation and Cognitive Training for Post-mTBI Depression N/A
Recruiting NCT04992130 - Sport Concussion Performance-Based Prevention Program N/A
Completed NCT05095012 - RECOVER Clinical Pathway for Pediatric Concussion N/A
Recruiting NCT05886400 - The Effects of Environmental Distractions on SCAT6 Outcomes N/A
Active, not recruiting NCT05400551 - Craneofacial Injuries in Rink Hockey Athletes
Recruiting NCT04121780 - Growth Hormone Replacement Therapy for Retried Professional Football Players Phase 2
Withdrawn NCT03575741 - Postural Control in Children and Adolescents After Suffering From a Concussion
Active, not recruiting NCT05471791 - Development of a Concussion Management Platform for Children and Youth N/A
Completed NCT04730167 - The Monaco Initiative for Concussion in Motorsport Pilots
Completed NCT03478059 - Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI N/A
Completed NCT04122274 - Comparing and Interactive Concussion Education Platform to Current Education Standards N/A
Completed NCT04558346 - Ghrelin (OXE--103) for Acute Concussion Management Phase 2
Completed NCT04074486 - Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
Not yet recruiting NCT05562232 - The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms N/A
Recruiting NCT05326555 - Dynamic Vision Testing and Concussion Management Dream Team 65
Completed NCT03671083 - Validation of Brain Function Assessment Algorithm for mTBI/Concussion
Completed NCT03170856 - The Effects of a Sub-maximal Exercise Program on Adolescents Who Sustained a Concussion N/A